BPG is committed to discovery and dissemination of knowledge
Article Citation
Bao ZH, Hu C, Zhang YQ, Yu PC, Wang Y, Xu ZY, Fu HY, Cheng XD. Safety and efficacy of a programmed cell death 1 inhibitor combined with oxaliplatin plus S-1 in patients with Borrmann large type III and IV gastric cancers. World J Gastrointest Oncol 2024; 16(4): 1281-1295 [PMID: 38660643 DOI: 10.4251/wjgo.v16.i4.1281]
Please LOGIN to submit a new comment.
Write to the Help Desk